Key result
In patients with severe myxomatous mitral regurgitation, holosystolic MR was associated with a higher risk of death and heart failure compared to mid-late systolic MR (HR 4.99; 95% CI 1.21-20.14).
Why the study?
Significant mitral regurgitation occurs as holosystolic or mid-late systolic with differences in volumetric impact on the left ventricle, but outcomes based on MR duration in degenerative MR patients undergoing exercise echocardiography were not well characterized.
Cohort (n=609)
Hazard Ratio: 4.99 (95% CI 1.21–20.14)
p-value: p=<0.05
HS MR signals higher event risk during exercise echo follow-up; extends observational data but leaves open need for prospective validation.
BACKGROUND: Significant mitral regurgitation (MR) typically occurs as holosystolic (HS) or mid-late systolic (MLS), with differences in volumetric impact on the left ventricle (LV). We sought to assess outcomes of degenerative MR patients undergoing exercise echocardiography, separated based on MR duration (MLS versus HS). METHODS AND RESULTS: We included 609 consecutive patients with ≥III+myxomatous MR undergoing exercise echocardiography: HS (n=487) and MLS (n=122). MLS MR was defined as delayed appearance of MR signal during mid-late systole on continuous-wave Doppler while HS MR occurred throughout systole. Composite events of death and congestive heart failure were recorded. Compared to MLS MR, HS MR patients were older (60±14 versus 53±14 years), more were males (72% versus 53%), and had greater prevalence of atrial fibrillation (16% versus 7%; all P<0.01). HS MR patients had higher right ventricular systolic pressure (RVSP) at rest (33±11 versus 27±9 mm Hg), more flail leaflets (36% versus 6%), and a lower number of metabolic equivalents (METs) achieved (9.5±3 versus 10.5±3), compared to the MLS MR group (all P<0.05). There were 54 events during 7.1±3 years of follow-up. On step-wise multivariable analysis, HS versus MLS MR (HR 4.99 [1.21 to 20.14]), higher LV ejection fraction (hazard ratio [HR], 0.94 [0.89 to 0.98]), atrial fibrillation (HR, 2.59 [1.33 to 5.11]), higher RVSP (HR, 1.05 [1.03 to 1.09]), and higher percentage of age- and gender-predicted METs (HR, 0.98 [0.97 to 0.99]) were independently associated with adverse outcomes (all P<0.05). CONCLUSION: In patients with ≥III+myxomatous MR undergoing exercise echocardiography, holosystolic MR is associated with adverse outcomes, independent of other predictors.
No takes yet. Share an insight, caveat, or question.
Naji et al. (2015) conducted a cohort in Myxomatous mitral regurgitation (n=609). Holosystolic mitral regurgitation vs. Mid-late systolic mitral regurgitation was evaluated on Composite events of death and congestive heart failure (HR 4.99, 95% CI 1.21 to 20.14, p=<0.05). In patients with severe myxomatous mitral regurgitation, holosystolic MR was associated with a higher risk of death and heart failure compared to mid-late systolic MR (HR 4.99; 95% CI 1.21-20.14).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: